Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rituximab in Relapsed Follicular Lymphoma Prior to and Following High-Dose Therapy
NCT00005589Phase 3Completed
- Sponsor
- EBMT Solid Tumors Working Party
- Start
- Oct 1999
- Modality
- Monoclonal Antibodies
- Countries
- 17
01
Overview
A Phase 3 trial of rituximab in follicular lymphoma (FL), sponsored by EBMT Solid Tumors Working Party. Started Oct 1999; status: completed.
02
Drugs
rituximab
03
Conditions
follicular lymphoma (FL)
Beyond the preview
Go deeper on NCT00005589.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00005589.